The SLC44A2 gene helps cells move choline, a nutrient they use to build and maintain cell membranes. If this gene does not work properly, cells in the inner ear may not function as they should, which can lead to hearing loss. In medicine, this gene is important because common differences in it also help define the HNA-3 blood group on white blood cells, which can affect rare immune reactions during transfusion or pregnancy.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Other genes mainly help manage when certain processes happen, where they happen, and how strongly they take place. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in LearnHub.
Overview
SLC44A2Gene function
What if the gene works
The SLC44A2 gene helps move choline into cells. This supports healthy cell membranes and the normal function of tissues including the inner ear and some blood and immune cells.
Risk
What if the gene does not work
Variants in the SLC44A2 gene are best known for causing sensorineural hearing loss. Effects can range from milder to more marked, and more disruptive variants may lead to earlier onset or broader inner ear involvement.
Treatment
What does that mean for your treatment
No SLC44A2-specific treatment or management approach is currently established for people with pathogenic or loss-of-function variants in the SLC44A2 gene. In research settings, SLC44A2 is being studied mainly as a transfusion medicine biomarker and as a possible target in clotting and inflammation pathways, but this has not yet changed routine treatment choices.
Gene function
What if the gene works
Choline is a basic nutrient your cells need every day. Your cells rely on the SLC44A2 gene to move some of this choline across cell membranes. This supports membrane upkeep and routine signaling, which helps explain what the SLC44A2 gene does in the body every day.
The SLC44A2 gene makes a transporter protein that helps move choline from outside the cell to the inside. This gives cells a steady supply of an important raw material.
Cells use choline delivered through the SLC44A2 gene's transporter to make phosphatidylcholine (a major fat in cell membranes). This helps cell membranes stay stable, flexible, and ready for daily work.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help make up normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC44A2 gene can alter the CTL2 protein’s shape, stability, or delivery to the cell surface, which helps explain how SLC44A2 gene variants affect protein function. Some changes only partly reduce activity, while more severe loss-of-function variants can sharply lower or stop protein production. When both gene copies are strongly affected, this is linked to hearing loss that may begin earlier or be more pronounced.
How variants are linked to conditions
Research on how variants in the SLC44A2 gene are linked to conditions points most strongly to two areas. Certain inherited variants can cause a rare form of hearing loss, while other common SLC44A2 gene differences define HNA-3 blood group types that are linked to immune reactions such as transfusion related acute lung injury and neonatal alloimmune neutropenia. These blood group variants do not mean a person will become ill, but they can matter in transfusion and pregnancy settings.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and are widely seen across the population. Most do not directly affect health and instead represent natural variation among people. In many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, one well understood variant in a particular gene is enough to establish the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC44A2 gene. If testing has found a change in SLC44A2, a doctor or genetic counselor can help explain what that result may mean for your personal and family risk.
Inheritance of SLC44A2 variants
There is not yet a single, broadly confirmed disease inheritance pattern that fully defines SLC44A2 inheritance across all reported health findings. Research on how SLC44A2 variants are inherited is still developing, and different reported effects of this gene have not been tied to one clear, widely accepted Mendelian pattern. The SLC44A2 gene is located on chromosome 19, which is an autosome, so a person inherits one copy from each parent.
What does my SLC44A2 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific condition for SLC44A2, though this understanding can change as research develops. If you have a specific SLC44A2 result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the context of your relatives and health history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for SLC44A2 variants usually uses a blood sample, saliva, or cheek swab. If you want to know how to find out about SLC44A2 variants, the lab reads the DNA sequence of the SLC44A2 gene and compares it with the usual sequence. Results can identify benign variants or changes that may matter clinically.
When should I consider getting a genetic test?
Consider testing related to the SLC44A2 gene if there is unexplained inherited hearing loss, especially when hearing problems begin early or several family members are affected. In that setting, this gene may be included on a hearing loss gene panel, which can help clarify the cause and what it may mean for relatives.
A genetic result is only one part of your health story
A genetic test result can provide useful insight, though what it can show varies by the condition and the kind of variant involved. Over time, factors such as lifestyle, environment, age, and medical history also influence how the body works. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when considered along with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how a person responds to medicines. Small inherited differences can affect how the body absorbs, breaks down, moves, or reacts to a drug, so the same treatment may work better for one person than for another. This is common and can shape both benefit and sensitivity to side effects.
What is Pharmacogenetics?
Pharmacogenetics studies how genetic differences can affect the way a person responds to medications. It examines connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can help support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the SLC44A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about medicines, side effects, or your general health are best discussed with your doctor.
History
SLC44A2 became historically important through transfusion medicine rather than public headlines. For years, doctors recognized a white blood cell marker called HNA-3 because some blood donors had antibodies against it, and these antibodies were linked to severe transfusion reactions. Initially understood only through visible traits, later recognized as tied to a specific gene, this marker was traced to the SLC44A2 gene in 2010. That finding helped explain why certain donor antibodies could cause transfusion related acute lung injury, often shortened to TRALI. From these first observations, research expanded steadily. SLC44A2 then gained wider interest in blood banking, platelet biology, and studies of clotting and stroke risk.